Target type: biologicalprocess
The glycosylation of protein via the O3 atom of peptidyl-threonine, forming O3-glycosyl-L-threonine; the most common forms are N-acetylgalactosaminyl, mannosyl, and galactosyl threonine. [RESID:AA0155]
Protein O-linked glycosylation via threonine is a post-translational modification where a sugar molecule is attached to the hydroxyl group of a threonine residue in a protein. This process is distinct from N-linked glycosylation, which occurs on asparagine residues.
The process typically begins with the activation of a sugar molecule, often N-acetylglucosamine (GlcNAc), by a specific enzyme called a glycosyltransferase. The activated sugar molecule is then transferred to the hydroxyl group of threonine by another glycosyltransferase, forming an O-linked glycosidic bond. The specific glycosyltransferase involved in this process determines the type of sugar added.
After the initial glycosylation event, the O-linked glycan can be further modified by the addition of other sugars, resulting in complex oligosaccharide structures. These modifications are carried out by a variety of glycosyltransferases and glycosidases.
O-linked glycosylation via threonine plays a critical role in various cellular processes, including:
* **Protein folding and stability:** O-linked glycosylation can influence the conformation and stability of proteins, contributing to their proper function.
* **Cellular signaling:** O-linked glycans can act as recognition signals for various cellular receptors, influencing cellular signaling pathways.
* **Immune recognition:** O-linked glycosylation patterns on proteins can influence immune responses, affecting the interaction with immune cells.
Overall, O-linked glycosylation via threonine is a complex and essential process that adds significant diversity and functionality to proteins, impacting a wide range of biological activities.'
"
Protein | Definition | Taxonomy |
---|---|---|
Polypeptide N-acetylgalactosaminyltransferase 6 | A polypeptide N-acetylgalactosaminyltransferase 6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8NCL4] | Homo sapiens (human) |
Polypeptide N-acetylgalactosaminyltransferase 13 | A polypeptide N-acetylgalactosaminyltransferase 13 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8IUC8] | Homo sapiens (human) |
Polypeptide N-acetylgalactosaminyltransferase 3 | A polypeptide N-acetylgalactosaminyltransferase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q14435] | Homo sapiens (human) |
Polypeptide N-acetylgalactosaminyltransferase 1 | A polypeptide N-acetylgalactosaminyltransferase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q10472] | Homo sapiens (human) |
Polypeptide N-acetylgalactosaminyltransferase 2 | A polypeptide N-acetylgalactosaminyltransferase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q10471] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
gallic acid | gallate : A trihydroxybenzoate that is the conjugate base of gallic acid. | trihydroxybenzoic acid | antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite |
pyrene | pyrene : An ortho- and peri-fused polycyclic arene consisting of four fused benzene rings, resulting in a flat aromatic system. pyrene: structure in Merck Index, 9th ed, #7746 | ortho- and peri-fused polycyclic arene | fluorescent probe; persistent organic pollutant |
ellagic acid | catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent | |
urolithin b | urolithin B: has antiproliferative activity; structure in first source | coumarins | |
urolithin d | urolithin D: has antiproliferative activity; structure in first source | hydroxycoumarin | |
3,3'-di-o-methylellagic acid | 3,3'-di-O-methylellagic acid: structure given in first source |